Universal Health Coverage

Universal Health Coverage (UHC)

{Photo credit: Tsion Issayas/MSH}Photo credit: Tsion Issayas/MSH

This post originally appeared on the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program blog as, "UHC Day 2016: Strong pharmaceutical management boosts access to essential medicines".

On this day (December 12) in 2014, the global health community made a commitment to universal health coverage (UHC) throughout the world. Although progress has been made, more than one billion people still lack access to basic health care. Further, as The Lancet Commission report, Essential Medicines for Universal Health Coverage, said in November, most low-income countries lack structural access to even basic essential medicines.

Bridging this gap requires system-wide interventions, such as strengthening the role of government, better medicines regulation, promoting quality use, and more transparency and accountability. These activities can reap big benefits.

With a sound pharmaceutical system, “for US $1–2 per month, every person in low-income and middle-income countries can have access to a basket of about 200 essential medicines,” according to the report.

{A woman at provincial health services department in Sri Lanka. (Photo Credit: Simone D. McCourtie/World Bank)}A woman at provincial health services department in Sri Lanka. (Photo Credit: Simone D. McCourtie/World Bank)

This article was originally published on Devex on November 18, 2016

As finance advisers in global health, we are regularly in conversations with health ministers in low- and middle-income countries who have been charged with the commendable but daunting task of achieving universal health coverage for their citizens.

In other words, they must ensure that all people obtain the health services they need without suffering financial hardship when paying for them, with special emphasis on serving the poor and disadvantaged. Our conversations often boil down to some key questions: How much will it cost, who will pay, and how do we ensure that funds are used effectively and responsibly?

MSH Vice President, Pharmaceuticals & Health Technologies Group, Dr. Douglas Keene, tells Devex how strong governance enables access to medicines.MSH Vice President, Pharmaceuticals & Health Technologies Group, Dr. Douglas Keene, tells Devex how strong governance enables access to medicines.

This week, Management Sciences for Health (MSH) and Devex are talking about how to maximize the impact of access to medicines in low- and middle-income countries. Below are excerpts, descriptions, videos, and links to the conversation. See the full conversation on Access to Medicines.

By strengthening governance and promoting transparency, developing countries can be better equipped to regulate the flow of medicines and support their efficient and effective use. Countries could make much progress by assuring the quality of medicines, but what is really being achieved in practice?

Recent global crises such as Ebola and Zika have revealed the dangers of weak health systems. As countries work to strengthen these systems, Dr. Douglas Keene, vice president of the pharmaceuticals & health technologies group at MSH, advises policymakers to first start by addressing existing regulations and governance.

{Photo credit: MSH staff, South Africa}Photo credit: MSH staff, South Africa

This post, first published on The Huffington Post, is part 5 in the MSH series on improving the health of the poorest and most vulnerable women, children, and communities by prioritizing prevention and preparing health systems for epidemics. Join the conversation online with hashtag .

Struck with a prolonged and worsening illness, Faith, a 37-year-old Nairobi woman raising her two children, sought help from local clinics. She came away each time with no diagnosis and occasionally an absurdly useless packet of antihistamines. Finally, a friend urged her to get an HIV test. When it came back positive, Faith wanted to kill herself, and got hold of a poison.

All epidemics arise from weak health systems, like the one that failed to serve Faith. Where people are poor and health systems are under-resourced, diseases like AIDS, Yellow Fever, Ebola, TB, Zika, Malaria, steadily march the afflicted to an early grave, decimating families, communities and economies along the way.

{Photo: MSH staff/Tanzania}Photo: MSH staff/Tanzania

Invest in teenage girls. Change the world.

Sylvia, age 16, knew little about HIV & AIDS or reproductive health when she started primary school. Now, she says: “I am not scared by the pressure from boys and other girls to engage in early sex, I know my rights and am determined to fulfill my vision of completing my education.” Sylvia is one of 485 girls in 6 eastern Ugandan schools who received integrated sexual and reproductive health and HIV information.

Today, July 11, we commemorate World Population Day 2016 and the midpoint toward reaching the Family Planning 2020 (FP2020) goal to ensure the right of 120 million additional women and girls to access contraception. More than half of the 7 billion people on earth are under the age of 30. Most of the FP2020 focus countries are in the very regions of the world where we find (a) the highest population of youth and (b) more marginalized and disenfranchised young people. In many of the world's poorest countries, people aged 15 to 29 will continue to comprise about half of the population for the next four decades.

 {Photo credit: Cindy Shiner/MSH}A mother waits for the nurse to vaccinate her baby during an immunization clinic at Phebe Hospital in central Liberia.Photo credit: Cindy Shiner/MSH

Stronger health systems are critical to preventing outbreaks from becoming epidemics. In fragile states, systems already weakened by conflict, disaster, or instability can crumble under the weight of an outbreak -- devastating access, availability, and quality of basic health for women and their families.

 {Photo credit: MSH staff}Irene Koek of USAID’s Global Health Bureau gives closing remarks at the health security side event in Geneva.Photo credit: MSH staff

This is the second in a new series on improving the health of the poorest and most vulnerable women, girls, families, and communities by prioritizing prevention and preparing health systems for epidemics (read Part 1). Join the conversation online with hashtag .

World Health Assembly and Beyond: Advancing the Global Health Security Agenda

Outbreaks are inevitable. Epidemics are preventable.

Last month, the No More Epidemics campaign convened a high-level, multi-sectoral panel on the Global Health Security Agenda during the 69th World Health Assembly (WHA69) in Geneva, Switzerland.

 {Photo credit: Matthew Martin/MSH}Mark R. Dybul, executive director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, expressed enthusiastic support for strategies combating epidemics in his keynote address.Photo credit: Matthew Martin/MSH

The No More Epidemics campaign convened a multi-sectoral panel on “Advancing the Global Health Security Agenda” at the 69th World Health Assembly in Geneva, Switzerland on May 25, 2016. Keynote speaker, Mark Dybul, MD, Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, expressed enthusiastic support for strategies combating epidemics. Dybul emphasized the importance of community level engagement in infectious disease preparedness and response, stressing that interventions cannot end at a health clinic, they must continue on to the “last mile”.

The panel was comprised of H.E. Kesetebirhan Admasu, MD, Minister of Health, Ethiopia; H.E. Aníbal Velasquez Valdivia, MD, Minister of Health, Peru; H.E. Elioda Tumwesigye, MD, Minister of Health, Uganda; as well as David Barash, MD, Chief Medical Officer, GE Foundation; and Minister Renne Klinge, Deputy Permanent Representative, Permanent Mission of Finland to Geneva.

The discussion, moderated by MSH President and CEO, Jonathan D. Quick, MD, MPH, highlighted the need to ensure that epidemic prevention, preparedness and response capabilities are sustainable under the Global Health Security Agenda (GHSA).

 {Photo credit: Rebecca Weaver/MSH} bit.ly/msh_May2016Photo credit: Rebecca Weaver/MSH

MSH is a worldwide leader in strengthening health care financing systems toward universal health coverage (UHC). Stronger systems. Stronger women and children.

MSH has made tremendous impact on health care financing and UHC in the last two decades.

Performance-based financing

In 1999, MSH pioneered performance-based financing in Haiti, and has continued to adapt and improve upon it since. We contributed to and supported Rwanda to design, implement, and achieve UHC through community-based health insurance and performance-based financing; drastically reduce maternal and child mortality; and meet all of its health Millennium Development Goals.

In Democratic Republic of the Congo, we contributed to drastic reductions in child mortality and some of the greatest results-based financing outcomes in two decades.

Altogether, we've designed and/or implemented performance-based financing interventions in 14 countries across 3 continents (sub-Saharan Africa, Latin America, and South-East Asia).

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

This post appears in its entirety on HuffPost Impact.

Pandemics are back on the agenda for the 2016 G7 Summit, which convenes this week in Ise-Shima, Japan. The Group of Seven is expected to further its commitments to global health security.

Look what has happened in less than one year since the G7 last met (June 2015), just after the Ebola crisis peaked at over 26,300 cases, 10,900 deaths.

Pages

Printer Friendly Version
Subscribe to RSS - Universal Health Coverage